Skip to main content

Human Recombinant Interleukin 2 Binds to Mouse Red Blood Cells via the Erythropoietin Receptor

  • Chapter
  • 71 Accesses

Abstract

Murine red blood cells (RBC) incubated with recombinant human interleukin 2 (rIL2) bound 10–20% of the added cytokine with 41.28 ± 4.64% of the population positive for bound cytokine as determined by fluorescence activated cell scanning (FACS) analysis. It has been well documented that a high degree of homology exists between the erythropoietin receptor (EPOR) and the IL2βR chain (based both on amino acid sequence and hydrophobicity alignment), we hypothesized that the rIL2 was binding to residual EPOR on murine RBC. Upon bioassay, it was found that reticulocytes (RET), which express a higher percentage of EPOR than normal RBC, bound 400% more rIL2 as compared to normal RBC. FACS analysis using fluorescently labeled rIL2 revealed a log higher fluorescence intensity on RET compared to RBC. Therefore, the population of immature or young RBC in circulation which are expressing residual EPOR are binding rIL2 due to cross-reactivity between the EPOR and IL2βR.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anstee, N. J., Gardner, B. K., Spring, F. A., Holmes, C. H., Simpson, K. L., Parsons, S. F., Mallinson, G., Yousaf, S. M., Judson, P. A. New monoclonal antibodies in CD44 and CD58:their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunol. 74, 197–205, 1991.

    CAS  Google Scholar 

  • Bartosz, G. Erythrocyte aging: physical and chemical membrane changes. Gerontology 37, 33–67, 1991.

    Article  PubMed  CAS  Google Scholar 

  • D’Andrea, A.D., Fasman, G., Wong, G., Lodish, H. Erythropoietin receptor: cloning strategy and structural features. Intl. J. of Cell Cloning 8(suppl 1), 173–180, 1990.

    Article  Google Scholar 

  • D’Andrea, A.D., Fasman, G.D., Lodish, H. Erythropoietin receptor and interleukin-2 receptor β chain: a new receptor family. Cell 58, 1023–1024, 1989.

    Article  PubMed  Google Scholar 

  • DeLoach, J.R., Andrews, K., Kruse, C. Encapsulation of human recombinant interleukin-2 into carrier erythrocytes by hypoosmotic dialysis and its subsequent biological activity. Adv. Biosciences 81, 59–65, 1991.

    CAS  Google Scholar 

  • DeLoach, J.R., Andrews, K., Sheffield, C.L. Encapsulation of Interleukin-2 in murine erythrocytes and subsequent deposition in mice receiving a subcutaneous injection. Biotech. Appl. Biochem. 10, 183–190, 1988.

    CAS  Google Scholar 

  • Djeu, J.Y., Liu, J.H., Wei, S., Rui, H., Pearson, C.A., Leonard, W.J., Blanchard, D.K. Function associated with IL2 receptor β on human neutrophils: mechanism of activation of antifungal activity against Candida albicans by IL2. J. Immunol. 150, 960–970, 1993.

    PubMed  CAS  Google Scholar 

  • Dutta-Roy, A.K., Hoque, L., Paterson, B.J. Prostaglandin-E l-binding sites in rabbit erythrocyte membranes. Eur. J. Biochem. 213, 1167–1173, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Fleishmann, J.D., Wentworth, D., Valencic, F., Imbembo, A.L., Kochler, K.A. Interleukin 2 self-association. Biochem. Biophys. Res. Comm. 152 (2), 879–885, 1988.

    Article  Google Scholar 

  • Horuk, R., Colby, T.J., Darbonne, W.C., Schall, T.J., Neote, K. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical charaterization, solubilization, and development of a binding assay for the soluble receptor. Biochem. 32, 5733–5738, 1993.

    Article  CAS  Google Scholar 

  • Kalechman, Y., Herman, S., Gafter, U., and Sredni, B. Enhancing effects of autologous erythrocytes on human or mouse cytokine secretion and IL-2R expression. Cell. Immunol. 148, 114–129, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Kirch, H.J., Moyes, R.B., Chiarantini, L., DeLoach, J.R. Effect of targeted erythrocytes coated with recombinant human interleukin 2 on T-lymphocyte proliferation in vitro. Biotechnol. Appl. Biochem. 19, 331–340, 1994.

    PubMed  CAS  Google Scholar 

  • Kniep, E.M., Strelow, I., Lohman-Matthes, M.-L. The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes. Immunol. 75, 299–304, 1992.

    CAS  Google Scholar 

  • Koury, M.J., Bondurant, M.C. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J. Cell. Physiol. 137, 65–74, 1988.

    Article  PubMed  CAS  Google Scholar 

  • Landschulz, K.T., Noyes, A.N., Rogers, O., Boyer, S.H. Erythropoeitin receptors on murine erythroid colonyforming units: natural history. Blood 73, 1476–1486, 1989.

    PubMed  CAS  Google Scholar 

  • Maggiano, N., Colotta, F., Castellino, F., Ricci, R., Valitutti, S., Larocca, L.M., Musiani, Rlnterleukin-2 receptor expression in human mast cells and basophils. Int. Arch. Allergy Appl. Immunol. 91, 8–14, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Moyes, R.B., Kirch, H.J., DeLoach, J.R. Immunotherapeutic evaluation of human recombinant interleukin 2 (rIL2) coated erythrocytes using the murine model. Adv Biosciences 92, 151–162, 1993.

    Google Scholar 

  • Nagler, A., Lanier, L.L., Phillips, J.H. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J. Exp. Med. 171, 1527–1533, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Paccaud, J.R, Carpentier, J.L., Schifferli, J.A. Direct evidence for the clustered nature of complement receptors type I on the erythrocyte membrane. J. Immunol. 141, 3889–3894, 1988.

    PubMed  CAS  Google Scholar 

  • Shau, H., Gupta, R.K., Golub, S.H. Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Cell. Immunol. 147, 1–11, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Smith, K.A. Interleukin 2. Ann. Rev. Immunol. 2, 319–333,1984.

    Article  CAS  Google Scholar 

  • Waldman, T.A. The IL-2/IL-2 receptor system: a target for rational immune intervention. Imm. Today 14, 264–270, 1993.

    Article  Google Scholar 

  • Youssofian, H., Longmore, G., Neumann, D., Yoshimura, A., Lodish, H. Structure, function, and activation of the erythropoietin receptor. Blood 81 (9), 2223–2236, 1993.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Moyes, R.B., DeLoach, J.R. (1997). Human Recombinant Interleukin 2 Binds to Mouse Red Blood Cells via the Erythropoietin Receptor. In: Sprandel, U., Way, J.L. (eds) Erythrocytes as Drug Carriers in Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0044-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0044-9_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0046-3

  • Online ISBN: 978-1-4899-0044-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics